Ni–Ga/ZrO 2 catalysts redirect CO 2 hydrogenation toward oxygenates at industrially relevant pressures
Chemical Communications · 2026 · 62 (87) · 22418-22422
DOI: 10.1039/d6cc04297j ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2026. Verfasst von Jean Castro da Cruz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Fundamental, Instituto de Química, Universidade de São Paulo, 05508-000, São Paulo, Brazil. lrossi@iq.usp.br. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Nickel is a versatile and tunable catalyst for CO 2 conversion. The Ni/ZrO 2 catalyst produced exclusively CH 4 , while the intermetallic Ni 3 Ga/ZrO 2 catalyst enables CO 2 hydrogenation into methanol.
Autor:innen und Institutionen
- Departamento de Química Fundamental, Instituto de Química, Universidade de São Paulo, 05508-000, São Paulo, Brazil. lrossi@iq.usp.br.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
da Cruz, J. C., Fuentes, D. P., Larico, B. A. L., Mendes, M. H. M., Braga, A. H., Vidinha, P., & Rossi, L. (2026). Ni–Ga/ZrO 2 catalysts redirect CO 2 hydrogenation toward oxygenates at industrially relevant pressures. Chemical Communications, 62(87), 22418-22422. https://doi.org/10.1039/d6cc04297j
Vancouver
da Cruz JC, Fuentes DP, Larico BAL, Mendes MHM, Braga AH, Vidinha P, et al. Ni–Ga/ZrO 2 catalysts redirect CO 2 hydrogenation toward oxygenates at industrially relevant pressures. Chemical Communications. 2026;62(87):22418-22422. doi:10.1039/d6cc04297j
BibTeX
@article{daCruz2026,
author = {da Cruz, Jean Castro and Fuentes, Dairon Perez and Larico, Bryan Alberto Laura and Mendes, Mattheus Henrique Moraes and Braga, Adriano Henrique and Vidinha, Pedro and Rossi, Liane},
title = {Ni–Ga/ZrO 2 catalysts redirect CO 2 hydrogenation toward oxygenates at industrially relevant pressures},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {87},
pages = {22418--22422},
doi = {10.1039/d6cc04297j}
}
EUVIMED